Results 241 to 250 of about 84,209 (281)

Quantification of Age and Sex Ratio Differences between Trial and Target Population for New Drugs

open access: yesClinical Pharmacology &Therapeutics, Volume 119, Issue 4, Page 1105-1111, April 2026.
Clinical trials are essential to understand the benefit‐harm profile of new drugs. Lack of adequate representation in age and sex ratio in clinical trials can result, for example, in higher side effects for underrepresented patients. We quantified differences in age and sex ratios between trial and target populations of new drugs approved by the FDA ...
Miquel Serra‐Burriel   +2 more
wiley   +1 more source

Genomic signature driving preinvasive to invasive processes in stage I lung adenocarcinoma

open access: yesInternational Journal of Cancer, Volume 158, Issue 7, Page 1975-1988, 1 April 2026.
What's new? The progression of lung cancer from minimally invasive adenocarcinoma (MIA) to invasive adenocarcinoma (IA) is a complex process involving molecular and microenvironment changes. Key molecular events that drive the invasion process, however, remain poorly characterized. In this comparison of gene profiles and differentially mutated genes in
Biqin Mou   +19 more
wiley   +1 more source

Reframing TB Care: A Perspective on Multimorbidity-Centered Care for People with TB. [PDF]

open access: yesTrop Med Infect Dis
Tabackman A   +3 more
europepmc   +1 more source

IgA Antibodies Reveal Covert Infection With Mpox Virus in People Living With HIV in the Community: A Prospective Longitudinal Cohort Survey

open access: yesMedComm, Volume 7, Issue 4, April 2026.
This study identified covert infection of MPXV among people living with HIV and MPXV‐IgA was the effective indicator. The combined use of two antigen protein set of MPXV (B6R plus E8L and E8L plus H3L) yield IgA test results comparable to those obtained with the MPXV.
Rui Song   +12 more
wiley   +1 more source

Youth stress, happiness, and life satisfaction across morbidity status: a gender-stratified analysis. [PDF]

open access: yesSci Rep
Ferro MA   +7 more
europepmc   +1 more source

Pilot study on the use of a multimorbidity index in patients receiving home parenteral nutrition

open access: yesNutrition in Clinical Practice, Volume 41, Issue 2, Page 554-561, April 2026.
Abstract Background Home parenteral nutrition (HPN) patients often have multiple comorbidities. A validated multimorbidity index (MMI) could help determine resource needs and risks with HPN. We evaluated MMI scoring to determine if it predicted HPN resource use and outcomes.
Michael M. Rothkopf   +7 more
wiley   +1 more source

The Future of the Obesity Management Landscape: Challenges, Opportunities and Solutions

open access: yesObesity Science &Practice, Volume 12, Issue 2, April 2026.
ABSTRACT Objective In July 2023 a diverse group of international experts from academia, healthcare and medical technology/pharmacological companies gathered to discuss the current global landscape in the management of obesity, identify the clinical challenges healthcare systems are facing, and the gaps in scientific knowledge. Approach We proposed ways
Alexander Dimitri Miras   +23 more
wiley   +1 more source

Multimorbidity patterns in elderly sleep disordered breathing patients. [PDF]

open access: yesERJ Open Res
Suusgaard J   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy